+++ 821.146 Press releases +++ 33.966 Newsrooms +++ 6.000 Media +++

febit Appoints Jack Leonard, Ph.D., Vice President of Technology Commercialization

(PresseBox) (Lexington, Mass. (USA)/Heidelberg, Germany, ) febit holding GmbH, a developer of the flexible and automated biochip-based DNA-analysis platform Geniom®, today announced the appointment of Jack Leonard, Ph.D., to the newly created position of Vice President of Technology Commercialization. He will be based in febit Inc.'s U.S. headquarters, which is located near Boston in Lexington, Mass..

In this new role, Dr. Leonard will apply his 15 years of product development experience in the life sciences to help accelerate the commercialization of febit's Geniom Platform and applications. Leonard will also head-up the febit Analytical Services Group in the U.S., which offers the HybSelect(TM) sequence capture service for DNA resequencing, as well as a wide range of microRNA (miRNA) and gene expression profiling services.

"We are pleased to have Jack join the team at febit, especially at a time when febit is expanding on U.S. business opportunities to provide technology and services to the life sciences community," said Cord F. Staehler, president and CEO of febit. "Jack's leadership will also support febit's plan to launch the HybSelect technology, which will provide the life sciences community with a highly developed DNA capture method, in early 2009."

"HybSelect has the potential to become a real blockbuster within genomics, and being part of the febit team is a privilege," said Leonard. "I look forward to applying my product development experience in genomics at febit to develop and establish the complete technology offering in the U.S. market, and to help extend the capabilities of febit's unique microfluidic microarray platform."

Leonard received his Ph.D. in Genetics from the University of Connecticut, and completed his post-doctoral research at New England Biolabs. Prior to joining febit, he was Director of Genomics and Molecular Biology at Millipore; R&D Director at U.S. Genomics; and most recently, Director of Process Development at Codon Devices, where he led the team that integrated automation, microfluidics, and molecular biology methods to build a high production DNA fabrication platform.

About CBC Comprehensive Biomarker Center GmbH

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications.

For more information about febit and its products please visit www.febit.com

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.